SUREPROTEIN
DEAD

Serial Number

79263982

Owner

FONTERRA TM LIMITED

Attorney

DENNIS CAVANAUGH

Filing Date

Mar 11, 2019

Add to watchlist:

No watchlists yet
View on USPTO

SUREPROTEIN Trademark

Serial Number: 79263982

SUREPROTEIN is a trademark filed by FONTERRA TM LIMITED on March 11, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 29 (Meats & Processed Foods). The application is currently no longer active.

Owner Contact Info

FONTERRA TM LIMITED (73 trademarks)

8 PRINCES STREET
AUCKLAND , NZ

Entity Type: 11

Trademark Details

Filing Date

March 11, 2019

Registration Date

Not Registered

Published for Opposition

July 14, 2020

Goods & Services

Chemicals and chemical preparations used in industry; protein by-products and dairy by-products for use in the food and the dietary supplement industry; casein for industrial purposes; casein for the food industry; casein concentrates for industrial purposes; casein concentrates for the food and beverage industry; calcium caseinate; sodium caseinate; chemical substances for preserving foodstuffs; protein ingredients for the food industry; whey protein for use in the food and the dietary supplement industry; whey protein isolates for use in the food and the dietary supplement industry; enzymes for the food industry; enzyme preparations for the food industry; milk ferments for the food industry; gluten for the food industry; glucose for the food industry; glucosides; lactose for the food industry; raw lactose; lecithin for the food industry; raw lecithin; adhesives in this class used in industry including the foodstuffs industry

Dairy products in this class and dairy based products for use in the production of food stuffs, namely, dairy based beverages and powders for making dairy based beverages; cow milk; sheep milk; goat milk; UHT milk; protein milk; condensed milk; milk powder; dried milk; milk beverages including flavoured and fortified milk beverages with milk predominating; milk substitutes in this class; cream; edible oils and fats; blends of edible oils and fats with dairy products; butter; butter blends; butter cream; margarine; food spreads namely, blends of margarine, butter and other edible oils; edible oils and fats and products included in this class consisting principally of edible oils or of edible fats for use in creaming coffee and coffee-based drinks, namely, cream, coffee creamer and edible oils and fats blends; textured and formed vegetable protein as a meat substitute and meat for human consumption; cheese and cheeses, including cheddar, ricotta, parmesan, feta, havarti, haloumi, cottage cheese, cream cheese, goat cheese, sheep cheese, soft and hard cheeses; cheese products, namely, cheese food and cheese curd; cultured dairy products, namely, sour cream and creme fraiche, yoghurt, yoghurt for drinking and yoghurt based drinks; dessert products in this class, dairy predominating, namely, custard-style yoghurt; whey; casein based dairy food products, namely, yoghurt, kefir, cheese, cream, curd, creamers for beverages, soups and preparations for making soups; casein based dairy beverages; fruit, vegetable, meat and dairy based spreads and preserves in this class including food spreads consisting principally of dairy products; fruit, vegetable, meat and dairy based preserves in this class; jellies for food

Pharmaceutical preparations and substances for supplementing normal diets or for providing dietary protein, vitamins or minerals; medical preparations and substances supplementing normal diets or for providing dietary protein, vitamins or minerals; dietetic foods and substances adapted for medical use, namely, meal replacement beverages and bars; biological food preparations for medical or dietetic use; food for babies and infants; infant and baby formula; powdered cow, goat and sheep milk for babies; milk containing supplements for medical or dietetic use; glucose for medical purposes; glucose dietary supplements; lactose for medical purposes; lactose for pharmaceutical purposes; enzyme dietary supplements; enzyme preparations for medical purposes; enzymes for medical purposes; lecithin dietary supplements; lecithin for medical purposes; ferments for medical purposes; ferments for pharmaceutical purposes; milk ferments for pharmaceutical purposes; milk ferments for medical purposes; food supplements; nutritional supplements; nutritional additives in the nature of nutritional supplements; casein dietary supplements; protein dietary supplements; nutraceutical preparations for therapeutic or medical purposes, namely, for supplementing normal diets or for providing dietary protein, vitamins or minerals; mineral supplements for foodstuffs; nutritional and dietary foods additives for medical or dietetic use; vitamin and mineral preparations for use as ingredients in the food industry; whey protein dietary supplements; whey protein isolate dietary supplements; food and dietary supplements for human consumption, other than medicated, or predominantly of vitamins, minerals or trace elements; all of the foregoing made in whole or significant part of protein

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Dec 5, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 12, 2023 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Mar 21, 2023 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 21, 2023 FICR
ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION
Mar 21, 2022 MAB4
ABANDONMENT - AFTER INTER PARTES DECISION
Mar 21, 2022 ABN4
OPPOSITION TERMINATED NO. 999999
Mar 21, 2022 OP.T
OPPOSITION DISMISSED NO. 999999
Mar 21, 2022 OP.D
REFUSAL PROCESSED BY IB
Feb 6, 2021 RFNT
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 23, 2021 OPNX
OPPOSITION INSTITUTED NO. 999999
Jan 13, 2021 OP.I
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Jan 11, 2021 OPNS
OPPOSITION NOTICE (IB REFUSAL) CREATED
Jan 9, 2021 OPNC
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 30, 2020 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 30, 2020 OPNR
EXTENSION OF TIME TO OPPOSE RECEIVED
Aug 12, 2020 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 14, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jul 14, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 24, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 9, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 9, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 9, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 9, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 9, 2020 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
May 12, 2020 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
May 5, 2020 PBCR
ASSIGNED TO LIE
Apr 17, 2020 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 8, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 8, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 8, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 8, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 8, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 27, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 26, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 26, 2020 TROA
REFUSAL PROCESSED BY IB
Jan 24, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 6, 2020 RFCS
REFUSAL PROCESSED BY MPU
Jan 6, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 10, 2019 RFCR
NON-FINAL ACTION WRITTEN
Dec 9, 2019 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Nov 9, 2019 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 18, 2019 RFCR
NON-FINAL ACTION WRITTEN
Oct 17, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
Sep 20, 2019 MAFR
ASSIGNED TO EXAMINER
Sep 16, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 16, 2019 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Aug 2, 2019 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 25, 2019 REPR